Intravitreal bevacizumab in congenital retinal macrovessel with retinal arteriolar macroaneurysm
SJO-Saudi Journal of Ophthalmology. 2015; 29 (4): 292-294
in English
| IMEMR
| ID: emr-173805
ABSTRACT
Congenital retinal macrovessel [CRM] refers to an aberrant vessel, usually a vein, which traverses the macula and supplies both sides of the horizontal raphe. It is a rare condition, mostly asymptomatic and discovered on routine examination. We describe a case of both arterial and venous CRM with a macroaneurysm along the arterial CRM that presented with decreased vision due to prominent lipid exudation at the macula. Treatment with intravitreal bevacizumab resulted in a favourable anatomical as well as functional outcome. To the best of our knowledge, this is the first report of this unusual presentation of CRM, and its successful management with intravitreal bevacizumab
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Retinal Artery
/
Retinal Diseases
/
Intravitreal Injections
/
Bevacizumab
/
Aneurysm
Type of study:
Case report
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Saudi J. Ophthalmol.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS